Log In

 

Company Name : Philip Morris International

Thursday, December 14, 2017 9:30AM IST (4:00AM GMT)

(BW)(NY-PHILIP-MORRIS-INTL)

Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program


An In-Depth Look at How Good Clinical Practices Ensure Ethical Conduct of High Quality Research and the Safety of Study Subjects


Lausanne, Switzerland

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link.

 

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/

 

Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Pr ...

Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire)

This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s commitment to the implementation of best practices, transparent research and the well-being of clinical trial participants.

 

Picavet stated, “The performance of clinical studies is a complicated process. Strict implementation of Good Clinical Practices is particularly important to assure the quality and consistency of the research and to address unexpected events that can occur during a study. These Practices are key to the validity of data and the safety of study participants.”

 

Beyond recent events and publications, this issue also describes PMI’s progress towards sharing all raw data from studies on IQOS in part through the new data-sharing platform called INTERVALS.

 

Prof. Manuel Peitsch, PMI’s Chief Scientific Officer, elaborates: “PMI is committed to openly sharing the research behind our smoke-free products. That’s why we are using our latest Scientific Update to explain the rigor behind our clinical program. We are going further by gradually making the data and results from the non-clinical and clinical program around our leading smoke-free product, IQOS, available to the public by early 2018.”

 

PMI’s extensive research and assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with the draft guidance of the U.S. FDA for Modified Risk Tobacco Product (MRTP) Applications. PMI employs over 400 world-class scientists, engineers and experts who conduct rigorous research, including laboratory and clinical studies, as well as ground-breaking systems toxicology. The assessment program also includes studies on actual product use and correct understanding of product communications, as well as post-market research.

 

About Philip Morris International Inc. (“PMI”)

 

Philip Morris International Inc. (PMI) is a leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products (RRPs). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see our PMI and PMI Science websites.

 

 

 

 
MULTIMEDIA AVAILABLE :
http://www.businesswire.com/news/home/20171212005891/en/


Click here for Media Contact Details
CONTACTS :

Media enquiries
Philip Morris International media office
T: +41 (0)58 242 4500
E: media@pmi.com


More News from Philip Morris International

21/03/2018 7:46PM

Philip Morris International Shifts Entire Capacity of Its Cigarette Factory in Greece to Smoke-Free Products

Philip Morris International Inc. (PMI) (NYSE: PM) announced today that the factory of its Greek affiliate (Papastratos) in Aspropyrgos, has ceased cigarette production and is now exclusively producing HEETS, the tobacco ...

21/02/2018 5:30PM

Philip Morris International and Scuderia Ferrari Partner Together to Advance the Vision of a World Free of Tobacco Smoke

Philip Morris International Inc. (NYSE/Euronext Paris: PMI) and Scuderia Ferrari have extended their partnership until 2021. Their successful collaboration spans more than 40 years. As of today, the partnership will be ...

18/02/2018 1:45PM

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to ...

Similar News

25/04/2018 5:10PM Image

YKBK Enterprise Brings the First Ever FIBA 3x3 Recognised Pro Basketball League to India, the 3BL - 3x3 Pro Basketball League

YKBK Enterprise brings the first ever FIBA 3x3 recognised Pro Basketball League to India, the 3BL – 3x3 Pro Basketball League.

No Image

25/04/2018 3:50PM Image

RMZ Corp: Largest LEED Certified Portfolio Under Arc Platform in India

Adding to the illustrious legacy of RMZ Corp’s reputation as an exemplary leader in Indian real estate, RMZ Ecoworld’s four campuses have been accorded the LEED Gold certification for the implementation of sustainable ...